Allied Market Research

2025

Japan Orphan Drugs Market

Japan Orphan Drugs Market, by DISEASE TYPE (ONCOLOGIC DISEASES, METABOLIC DISEASES, HEMATOLOGIC AND IMMUNOLOGIC DISEASES, INFECTIOUS DISEASES, NEUROLOGIC DISEASES, OTHER RARE DISEASES) and, by INDICATION (NON-HODGKIN LYMPHOMA, ACUTE MYELOID LEUKEMIA, CYSTIC FIBROSIS, GLIOMA, PANCREATIC CANCER, OVARIAN CANCER, MULTIPLE MYELOMA, DUCHENNE MUSCULAR DYSTROPHY, GRAFT VS HOST DISEASE, RENAL CELL CARCINOMA, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date: